Mounica Vallurupalli, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Copper | 2 | 2019 | 365 | 1.100 |
Why?
|
Celiac Disease | 2 | 2019 | 821 | 0.750 |
Why?
|
Anemia, Macrocytic | 1 | 2019 | 53 | 0.660 |
Why?
|
Duodenum | 2 | 2019 | 495 | 0.660 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 272 | 0.510 |
Why?
|
Zinc | 1 | 2019 | 675 | 0.490 |
Why?
|
Interleukin-1beta | 1 | 2020 | 1027 | 0.450 |
Why?
|
Adaptation, Psychological | 2 | 2013 | 2662 | 0.380 |
Why?
|
Grief | 1 | 2013 | 256 | 0.360 |
Why?
|
Anemia | 1 | 2020 | 1514 | 0.350 |
Why?
|
Antibodies, Neutralizing | 1 | 2019 | 2011 | 0.330 |
Why?
|
Bone Marrow | 1 | 2019 | 2926 | 0.320 |
Why?
|
Death | 1 | 2013 | 685 | 0.310 |
Why?
|
Religion | 1 | 2011 | 376 | 0.300 |
Why?
|
Spirituality | 1 | 2011 | 430 | 0.270 |
Why?
|
Hemoglobins | 2 | 2020 | 1531 | 0.220 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9245 | 0.200 |
Why?
|
Cystic Fibrosis | 1 | 2012 | 1292 | 0.200 |
Why?
|
Fatigue | 2 | 2019 | 1556 | 0.200 |
Why?
|
Dyspnea | 2 | 2019 | 1352 | 0.190 |
Why?
|
Mutagenesis | 1 | 2024 | 1227 | 0.180 |
Why?
|
Myelodysplastic Syndromes | 2 | 2021 | 1399 | 0.170 |
Why?
|
Anemia, Hypochromic | 1 | 2019 | 62 | 0.170 |
Why?
|
Palliative Care | 2 | 2012 | 3641 | 0.170 |
Why?
|
Bone Marrow Examination | 1 | 2019 | 154 | 0.160 |
Why?
|
Deficiency Diseases | 1 | 2019 | 74 | 0.160 |
Why?
|
DNA Helicases | 1 | 2024 | 854 | 0.160 |
Why?
|
Physician-Patient Relations | 1 | 2012 | 3266 | 0.150 |
Why?
|
Internship and Residency | 2 | 2021 | 5947 | 0.150 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2018 | 187 | 0.150 |
Why?
|
Endoscopy, Digestive System | 1 | 2019 | 358 | 0.140 |
Why?
|
Diet, Gluten-Free | 1 | 2019 | 285 | 0.140 |
Why?
|
Nausea | 1 | 2019 | 682 | 0.130 |
Why?
|
Stress, Psychological | 1 | 2012 | 4526 | 0.130 |
Why?
|
Hemangiosarcoma | 1 | 2018 | 214 | 0.130 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 724 | 0.130 |
Why?
|
Antifibrinolytic Agents | 1 | 2018 | 289 | 0.120 |
Why?
|
Physicians | 1 | 2013 | 4593 | 0.120 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12986 | 0.110 |
Why?
|
Cyclin D1 | 1 | 2015 | 453 | 0.110 |
Why?
|
Guilt | 1 | 2013 | 92 | 0.100 |
Why?
|
Neoplasms | 3 | 2023 | 22350 | 0.100 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2015 | 562 | 0.100 |
Why?
|
DNA Repair | 1 | 2021 | 2050 | 0.090 |
Why?
|
Quality of Life | 1 | 2011 | 13485 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2020 | 3227 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 940 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 3440 | 0.080 |
Why?
|
Teaching Rounds | 1 | 2013 | 282 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2023 | 3667 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3851 | 0.070 |
Why?
|
Drug Discovery | 1 | 2015 | 1068 | 0.070 |
Why?
|
Recurrence | 1 | 2019 | 8504 | 0.070 |
Why?
|
Neutrophils | 1 | 2019 | 3779 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4210 | 0.070 |
Why?
|
Medical Oncology | 3 | 2023 | 2341 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2020 | 12451 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2021 | 3626 | 0.060 |
Why?
|
Middle Aged | 6 | 2020 | 223233 | 0.060 |
Why?
|
Female | 9 | 2021 | 396660 | 0.060 |
Why?
|
Humans | 15 | 2024 | 767040 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1837 | 0.060 |
Why?
|
Membrane Transport Proteins | 1 | 2009 | 1029 | 0.050 |
Why?
|
Mice, SCID | 2 | 2021 | 2626 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2563 | 0.050 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2024 | 330 | 0.050 |
Why?
|
Anticoagulants | 1 | 2018 | 4854 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4357 | 0.050 |
Why?
|
Lung Transplantation | 1 | 2012 | 1310 | 0.050 |
Why?
|
Hearing Loss | 1 | 2009 | 785 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 21526 | 0.050 |
Why?
|
U937 Cells | 1 | 2021 | 260 | 0.040 |
Why?
|
Autoantibodies | 1 | 2009 | 2114 | 0.040 |
Why?
|
Mutation | 2 | 2024 | 30211 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3608 | 0.040 |
Why?
|
Students, Medical | 1 | 2013 | 1965 | 0.040 |
Why?
|
RNA Splicing | 1 | 2024 | 903 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3928 | 0.040 |
Why?
|
K562 Cells | 1 | 2021 | 644 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5693 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11513 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2009 | 3702 | 0.040 |
Why?
|
Phthalazines | 1 | 2021 | 397 | 0.040 |
Why?
|
Accreditation | 1 | 2021 | 477 | 0.040 |
Why?
|
Decision Making | 1 | 2012 | 3951 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 7848 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2021 | 1751 | 0.040 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2824 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2255 | 0.030 |
Why?
|
Male | 6 | 2021 | 364203 | 0.030 |
Why?
|
Thrombopoietin | 1 | 2018 | 225 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2024 | 4280 | 0.030 |
Why?
|
Receptors, Fc | 1 | 2018 | 537 | 0.030 |
Why?
|
RNA-Binding Protein EWS | 1 | 2015 | 211 | 0.030 |
Why?
|
Aged | 2 | 2020 | 171319 | 0.030 |
Why?
|
Lung | 1 | 2012 | 10076 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13650 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2015 | 352 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 559 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 17097 | 0.020 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2018 | 1126 | 0.020 |
Why?
|
DNA Damage | 1 | 2021 | 2469 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2015 | 1168 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 26325 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 3738 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1903 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2021 | 2420 | 0.020 |
Why?
|
Chromatin | 1 | 2021 | 2980 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9551 | 0.020 |
Why?
|
Curriculum | 1 | 2021 | 3786 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 5753 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2829 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5794 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 1647 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5750 | 0.020 |
Why?
|
Ear, Inner | 1 | 2009 | 426 | 0.020 |
Why?
|
Adolescent | 1 | 2012 | 89046 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22361 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18330 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8628 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11872 | 0.010 |
Why?
|
Animals | 2 | 2021 | 168965 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81912 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40154 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23621 | 0.010 |
Why?
|
Adult | 1 | 2009 | 223317 | 0.000 |
Why?
|